Article info

Download PDFPDF

Original research
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort

Authors

  • Marie-Elise Truchetet Rheumatology Department, University Hospital Centre Bordeaux Pellegrin Hospital Group, Bordeaux, Aquitaine, France PubMed articlesGoogle scholar articles
  • Elodie Drumez Department of Biostatistics, CHU Lille, Lille, Hauts-de-France, France PubMed articlesGoogle scholar articles
  • Thomas Barnetche Rheumatology Department, University Hospital Centre Bordeaux Pellegrin Hospital Group, Bordeaux, Aquitaine, France PubMed articlesGoogle scholar articles
  • Claire Martin Department of Biostatistics, CHU Lille, Lille, Hauts-de-France, France PubMed articlesGoogle scholar articles
  • Mathilde Devaux Department of Internal Medicine, Centre Hospitalier Intercommunal de Poissy-Saint-Germain-en-Laye, Saint-Germain-en-Laye, Île-de-France, France PubMed articlesGoogle scholar articles
  • Tiphaine Goulenok Department of Internal Medicine, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Université de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Alexandre Maria Department of Internal Medicine, Saint-Eloi Hospital Department of Internal Medicine, Montpellier, Languedoc-Roussillon, France PubMed articlesGoogle scholar articles
  • Jean Schmidt Department of Internal Medicine and RECIF, Amiens University Hospital, Amiens, FranceUniversité de Picardie Jules Verne, Amiens, Hauts-de-France, France PubMed articlesGoogle scholar articles
  • Nassim Ait Abdallah Unité de Médecine Interne (UF 04): CRMR MATHEC, Maladies auto-immunes et thérapie cellulaire; Centre de Référence des Maladies auto-immunes systémiques Rares d’Ile-de-France MATHEC, AP-HP, Hôpital St-Louis, Paris, FranceIRSL, Recherche clinique appliquée à l'hématologie, EA3518 (Equipe 3 MATHEC-EUROCORD), Université de Paris, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Isabelle Melki Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris, FranceDepartment of General Paediatrics, Infectious Diseases and Internal Medicine, Hopital Universitaire Robert Debre, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Eric Hachulla Department of Internal Medicine and Clinical immunology, Referral Centre for Rare Systemic Auto-immune Diseases North and North-West of France, Lille University School of Medicine, Lille, France PubMed articlesGoogle scholar articles
  • Christophe Richez Rheumatology Department, University Hospital Centre Bordeaux Pellegrin Hospital Group, Bordeaux, Aquitaine, France PubMed articlesGoogle scholar articles
  1. Correspondence to Pr Marie-Elise Truchetet; marie-elise.truchetet{at}chu-bordeaux.fr
View Full Text

Citation

Truchetet M, Drumez E, Barnetche T, et al
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort

Publication history

  • Received May 18, 2022
  • Accepted August 5, 2022
  • First published September 16, 2022.
Online issue publication 
September 16, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.